Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,474.00    0.00 (0.00%)
Bid:
2,000.00
Ask:
2,782.00
Spread: 782.00 (39.10%)
Market Cap: £7.94b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

21 Oct 2025 07:00

RNS Number : 0892E
Bunzl PLC
21 October 2025
 

21 October 2025

 

BUNZL Q3 TRADING STATEMENT

IN-LINE WITH EXPECTATIONS; FY GUIDANCE UNCHANGED

 

Bunzl plc, the specialist international distribution and services Group, today announces its trading statement for the period since 30 June 2025.

Group revenue in the quarter grew by 0.6% at constant exchange rates. Underlying revenue1, which is organic revenue adjusted for trading days, increased by 0.4%, in line with our expectations, against what remain challenging end markets in our key business areas. Net acquisitions2 contributed growth of 1.4% at constant exchange rates, while fewer trading days in the period impacted revenue by 1.1%. Overall, at actual exchange rates, Group revenue declined by 0.8%. In-line with expectations, the year-on-year operating margin decline over the quarter moderated compared to the first half of the year.

The Group's full year guidance remains unchanged. The Group continues to expect moderate revenue growth in 2025, at constant exchange rates, driven by announced acquisitions and broadly flat underlying revenue. Group operating margin for the year is expected to be moderately below 8.0%, compared to 8.3% in 2024, with a continued expectation for a moderation of year-on-year operating margin decline in the second half, compared to the first half.

We have now completed c.£190 million of our announced £200 million 2025 buyback. The Group continues to expect leverage to be just over, and towards, 2.0 times at the end of 2025, after potential acquisition spend and the completion of the buyback.

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

"In what remains a challenging market, we remain strongly focused on improving performance across the business. As we enter the important final quarter, I am pleased to see the actions that we have taken driving operational improvements, as expected. We reiterate our Group outlook for 2025.

As highlighted in our recent investor seminar, we remain confident in the significant opportunities we see for continued acquisition growth. We have completed seven acquisitions year-to-date and our pipeline is active. I remain confident in the Group's underlying resilience and strength, and ability to deliver consistent compounding growth in the medium-term."

 

Enquiries:

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations and Communications

Tel: +44 (0)20 7725 5000

 

Teneo

Martin Robinson

Kate Somerville

Tel: +44 (0)20 7353 4200

 

 

 

 

1. Growth in hyperinflationary economies was not in excess of 26% per annum.

2. Acquisition growth of 1.8%, net of a 0.4% reduction related to disposals.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUBDGGUDDGUG
Date   Source Headline
15th Mar 20184:27 pmRNSAnnual Financial Report
12th Mar 20184:48 pmRNSDirector/PDMR Shareholding
5th Mar 201811:54 amRNSHolding(s) in Company
2nd Mar 20184:16 pmRNSDirector/PDMR Shareholding
2nd Mar 20183:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20183:23 pmRNSDirector/PDMR Shareholding
1st Mar 201811:06 amRNSTotal Voting Rights
26th Feb 201810:22 amRNSDividend Declaration
26th Feb 20187:00 amRNSFinal Results
23rd Feb 20188:00 amRNSAdditional Listing
22nd Feb 20183:30 pmRNSDirector Declaration
13th Feb 20189:06 amRNSHolding(s) in Company
2nd Feb 20184:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20188:00 amRNSAdditional Listing
1st Feb 20184:12 pmRNSTotal Voting Rights
22nd Jan 20188:00 amRNSAdditional Listing
11th Jan 20187:00 amRNSImpact of US Tax Legislation
11th Jan 20187:00 amRNSAcquisition
9th Jan 20184:47 pmRNSDirector/PDMR Shareholding
3rd Jan 20181:38 pmRNSDirector/PDMR Shareholding
2nd Jan 20184:08 pmRNSTotal Voting Rights
21st Dec 20178:00 amRNSAdditional Listing
18th Dec 20174:00 pmRNSHolding(s) in Company
14th Dec 20177:00 amRNSTrading Statement
13th Dec 20179:11 amRNSHolding(s) in Company
7th Dec 201711:36 amRNSIssue of Debt
1st Dec 20174:12 pmRNSTotal Voting Rights
1st Dec 20177:00 amRNSIssue of Debt
30th Nov 20178:00 amRNSAdditional Listing
23rd Nov 20177:00 amRNSAcquisition
17th Nov 20171:18 pmRNSDirector/PDMR Shareholding
15th Nov 201711:49 amRNSHolding(s) in Company
13th Nov 20173:01 pmRNSDividend Reinvestment Plan Terms and Conditions
1st Nov 20173:05 pmRNSBlock listing Interim Review
1st Nov 20172:57 pmRNSTotal Voting Rights
24th Oct 20177:00 amRNSTrading Statement
12th Oct 201710:45 amRNSDirector/PDMR Shareholding
9th Oct 20175:30 pmRNSDirector/PDMR Shareholding
9th Oct 20175:25 pmRNSDirector/PDMR Shareholding
9th Oct 20175:21 pmRNSDirector/PDMR Shareholding
6th Oct 20174:00 pmRNSDirector/PDMR Shareholding
6th Oct 201712:20 pmRNSDirector/PDMR Shareholding
5th Oct 20173:55 pmRNSHolding(s) in Company
2nd Oct 201711:30 amRNSTotal Voting Rights
29th Sep 20174:15 pmRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSCapital Markets Event
22nd Sep 20173:00 pmRNSDirector/PDMR Shareholding
14th Sep 20179:10 amRNSHolding(s) in Company
6th Sep 20179:07 amRNSHolding(s) in Company
1st Sep 20174:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.